<DOC>
	<DOCNO>NCT00875017</DOCNO>
	<brief_summary>The purpose study compare absorption dietary phosphorus follow single dose lanthanum carbonate ( 1000mg ) single dose sevelamer carbonate ( 2400mg ) .</brief_summary>
	<brief_title>Comparing Absorption Dietary Phosphorus When Administering FOSRENOL® RENVELA® Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Sevelamer</mesh_term>
	<criteria>Inclusion Criteria Ability provide inform consent participate study . Healthy volunteer , age 1945 inclusive . Subject must willing comply applicable contraceptive requirement protocol Female subject must negative pregnancy test Satisfactory medical assessment clinically significant relevant abnormality medical history , physical examination , vital sign , ECG laboratory evaluation . Body Mass Index ( BMI ) 20.0 29.9kg/m² inclusive . Serum 1.25 dihydroxy vitamin D3 &gt; 30pg/mL . Ability chew swallow dose investigational product mannitol solution prescribe protocol . Ability willingness fast 24 hour . Exclusion Criteria Current recurrent disease could affect action , absorption disposition investigational product utilized study , could affect clinical laboratory assessment . Current relevant previous history physical psychiatric illness , medical disorder may require treatment make subject unlikely fully complete study , condition present undue risk investigational product study procedure . Significant illness within 2 week first dose investigational product . Current use medication exception hormonal replacement therapy hormonal contraceptive within 14 day first dose investigational product . Known suspect intolerance hypersensitivity investigational product ( ) mannitol solution , closely related compound state ingredient . History alcohol substance abuse within last year . A positive screen alcohol drug abuse . Male subject consume 21 unit alcohol per week three unit per day . Female subject consume 14 unit alcohol per week two unit per day . A positive human immunodeficiency virus ( HIV ) antibody screen , Hepatitis B surface antigen ( HBsAg ) Hepatitis C virus ( HCV ) antibody screen . Use tobacco form nicotinecontaining product form . Exusers must report stop use tobacco least 30 day prior receive first dose investigational product . Routine consumption two unit caffeine per day subject experience caffeine withdrawal headache . Donation blood blood product within 60 day prior receive first dose investigational product . Use another investigational product within 30 day prior receive first dose investigational product active enrolment another drug vaccine clinical study . An inability follow standardize diet and/or meal schedule , require study . Substantial change eat habit within 30 day prior receive first dose investigational product , assessed Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>